{
  "trial_id": "NCT01767792",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, diagnosis confirmation method, tumor volume, Karnofsky performance status, leukocyte count, absolute neutrophil count, platelet count, total bilirubin level, AST (SGOT) level, ALT (SGPT) level, creatinine clearance or GFR, word recognition score, prior treatments, history of allergic reactions, cardiovascular disease history, hypertension status, cerebrovascular accident history, myocardial infarction history, heart failure status, cardiac arrhythmia status, vascular disease history, peripheral vascular disease status, pregnancy status, HIV status, coagulopathy history, CNS hemorrhage history, urine protein level, wound healing status, history of abdominal fistula or gastrointestinal perforation, history of invasive procedures, prior bevacizumab treatment.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Word recognition score in target ear",
          "word recognition score"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "gender",
        "diagnosis confirmation method",
        "tumor volume",
        "Karnofsky performance status",
        "leukocyte count",
        "absolute neutrophil count",
        "platelet count",
        "total bilirubin level",
        "AST (SGOT) level",
        "ALT (SGPT) level",
        "creatinine clearance or GFR",
        "prior treatments",
        "history of allergic reactions",
        "cardiovascular disease history",
        "hypertension status",
        "cerebrovascular accident history",
        "myocardial infarction history",
        "heart failure status",
        "cardiac arrhythmia status",
        "vascular disease history",
        "peripheral vascular disease status",
        "pregnancy status",
        "HIV status",
        "coagulopathy history",
        "CNS hemorrhage history",
        "urine protein level",
        "wound healing status",
        "history of abdominal fistula or gastrointestinal perforation",
        "history of invasive procedures",
        "prior bevacizumab treatment"
      ]
    },
    "processed-gen-response": "Age, gender, diagnosis confirmation method, tumor volume, Karnofsky performance status, leukocyte count, absolute neutrophil count, platelet count, total bilirubin level, AST (SGOT) level, ALT (SGPT) level, creatinine clearance or GFR, word recognition score, prior treatments, history of allergic reactions, cardiovascular disease history, hypertension status, cerebrovascular accident history, myocardial infarction history, heart failure status, cardiac arrhythmia status, vascular disease history, peripheral vascular disease status, pregnancy status, HIV status, coagulopathy history, CNS hemorrhage history, urine protein level, wound healing status, history of abdominal fistula or gastrointestinal perforation, history of invasive procedures, prior bevacizumab treatment."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Karnofsky performance status, Leukocyte count, Absolute neutrophil count, Platelet count, Total bilirubin, AST (SGOT), ALT (SGPT), Creatinine clearance, Word recognition score, Tumor volume,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Word recognition score in target ear",
          "Word recognition score"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Karnofsky performance status",
        "Leukocyte count",
        "Absolute neutrophil count",
        "Platelet count",
        "Total bilirubin",
        "AST (SGOT)",
        "ALT (SGPT)",
        "Creatinine clearance",
        "Tumor volume"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Karnofsky performance status, Leukocyte count, Absolute neutrophil count, Platelet count, Total bilirubin, AST (SGOT), ALT (SGPT), Creatinine clearance, Word recognition score, Tumor volume"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Neurofibromatosis Type 2 diagnosis duration, Karnofsky performance status, Word recognition score, Vestibular schwannoma volume, Creatinine clearance or radioisotope GFR, Serum creatinine, AST, ALT, Bilirubin, Leukocytes, Absolute neutrophil count, Platelets.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Word recognition score in target ear",
          "Word recognition score"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Neurofibromatosis Type 2 diagnosis duration",
        "Karnofsky performance status",
        "Vestibular schwannoma volume",
        "Creatinine clearance or radioisotope GFR",
        "Serum creatinine",
        "AST",
        "ALT",
        "Bilirubin",
        "Leukocytes",
        "Absolute neutrophil count",
        "Platelets"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Neurofibromatosis Type 2 diagnosis duration, Karnofsky performance status, Word recognition score, Vestibular schwannoma volume, Creatinine clearance or radioisotope GFR, Serum creatinine, AST, ALT, Bilirubin, Leukocytes, Absolute neutrophil count, Platelets."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, Karnofsky performance status, life expectancy, diagnosis of neurofibromatosis 2, presence of progressive vestibular schwannomas, word recognition score, tumor volume, creatinine clearance or radioisotope glomerular filtration rate, serum creatinine, leukocytes, absolute neutrophil count, platelets, total bilirubin, AST, ALT, history of allergic reactions, history of arterial/myocardial disease, history of cerebrovascular accident, history of myocardial infarction, history of congestive heart failure, history of cardiac arrhythmia, history of vascular disease, history of peripheral vascular disease.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Word recognition score in target ear",
          "word recognition score"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "Karnofsky performance status",
        "life expectancy",
        "diagnosis of neurofibromatosis 2",
        "presence of progressive vestibular schwannomas",
        "tumor volume",
        "creatinine clearance or radioisotope glomerular filtration rate",
        "serum creatinine",
        "leukocytes",
        "absolute neutrophil count",
        "platelets",
        "total bilirubin",
        "AST",
        "ALT",
        "history of allergic reactions",
        "history of arterial/myocardial disease",
        "history of cerebrovascular accident",
        "history of myocardial infarction",
        "history of congestive heart failure",
        "history of cardiac arrhythmia",
        "history of vascular disease",
        "history of peripheral vascular disease"
      ]
    },
    "processed-gen-response": "Age, sex, Karnofsky performance status, life expectancy, diagnosis of neurofibromatosis 2, presence of progressive vestibular schwannomas, word recognition score, tumor volume, creatinine clearance or radioisotope glomerular filtration rate, serum creatinine, leukocytes, absolute neutrophil count, platelets, total bilirubin, AST, ALT, history of allergic reactions, history of arterial/myocardial disease, history of cerebrovascular accident, history of myocardial infarction, history of congestive heart failure, history of cardiac arrhythmia, history of vascular disease, history of peripheral vascular disease."
  }
}